|
Cytogenix Incorporated - Company Profile Snapshot
| Company Profile: |
Cytogenix Incorporated |
| Ticker: |
CYGX |
| Exchanges: |
OTC |
| 2008 Sales: |
52,348 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Service Organizations |
| Country: |
UNITED STATES |
| Employees: |
3 |
Business Description
Cytogenix Incorporated. The Company's principal activities are developing and marketing proprietary technology for identifying and silencing disease causing genes. The technology of the Company prevents genetically diseased cells from manufacturing harmful proteins, thereby preventing disease. It owns patented intracellular expression system technology (CYGXes) to produce any desired sequence-specific, ssDNA molecules (ODN) in individual cells for the purpose of triplex, antisense, catalytic DNA, and aptamer applications. It seeks to market and license its technology to biotechnology companies owning DNA sequences in the Human Genome and to assist in their determination of the function and purpose of these sequences. The Company primarily operates in the United States.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
